Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Human papillomavirus and squamous cell carcinoma of the urinary bladder: DaBlaCa-10 study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Development and validation of a simulator-based test in transurethral resection of bladder tumours (TURBEST)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Educational level and first-time PSA testing in general practice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Successful extraction of sperm cells after autologous bone marrow transplant: a case report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Luteinizing Hormone Receptor Is Expressed in Testicular Germ Cell Tumors: Possible Implications for Tumor Growth and Prognosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. DaBlaCa-11: Photodynamic Diagnosis in Flexible Cystoscopy-A Randomized Study With Focus on Recurrence

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVE: To evaluate a potential association between Human Papillomavirus (H.P.V.) and squamous cell carcinoma (S.C.C.) urinary bladder cancer (B.C.). Furthermore, the relation between p16INK4a, H.P.V. and B.C. was examined.

PATIENTS AND METHODS: Patients were included and divided into three groups based on the histological diagnosis of B.C.

SPECIMENS: An extensive exclusion was performed, including accepted casual risk factors for S.C.C. B.C., such as long-term use of catheters, cystolithiasis and Schistosoma hematobium infection. A total of 100 patients were included: 50 with pure S.C.C., 25 with urothelial carcinomas (U.C.) and 25 with squamous differentiation of U.C. (Sq.D.). The patients were operated at one of four major Danish hospitals in the period January 2005 to December 2016. Clinical information was collected from the medical records. Presence of H.P.V. was analyzed using the INNO-LiPA H.P.V. Genotyping Extra II. p16INK4a was analyzed using immunohistochemical (I.H.C.) staining. A p-value <0.05 was considered statistically significant.

RESULTS: An overall H.P.V. prevalence of 12/100 (12%) was observed. H.P.V. was demonstrated in 9/50 (18%) of the S.C.C.

PATIENTS: Overall, p16INK4a over-expression was observed in 52/100 (52%) patients. However, concomitant H.P.V. positivity and p16INK4a over-expression were observed in only 4/100 (4%) patients.

CONCLUSION: The presence of H.P.V. in one fifth of patients with S.C.C. B.C. was demonstrated. H.P.V. infection could have a significant association with S.C.C. B.C. without other known casual risk factors for S.C.C. B.C.

OriginalsprogEngelsk
TidsskriftScandinavian Journal of Urology
Vol/bind52
Udgave nummer5-6
Sider (fra-til)371-376
ISSN2168-1805
DOI
StatusUdgivet - 2019

ID: 56245976